
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded rectal suppository containing hydrocortisone and lidocaine hydrochloride, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
No FDA-approved product combines hydrocortisone and lidocaine.
FDA-approved products containing hydrocortisone are listed in lotion, cream, ointment, solution, aerosol, tablet, granule, injection and enema forms, and in ear, eye and rectal suspension forms. No FDA-approved hydrocortisone product is listed in suppository form; suppository products containing it are filed as unapproved drugs.
FDA-approved products containing lidocaine are listed in injection, ointment, patch, solution and jelly forms, and in cream form only in combination with another active ingredient. No finished lidocaine product of any kind is listed in suppository form. None of the FDA-approved lidocaine products is for rectal use; products for rectal use containing it are filed as over-the-counter monograph drugs and unapproved drugs.
Suppository bases differ, and the base used decides how USP <795> classifies the preparation for beyond-use dating. The date printed on the label is the one to follow.
Wash your hands. Chill the rocket briefly if it is soft, unwrap it and moisten the tip with water. Lie on your side and insert it as your pharmacist showed you; part of the suppository is designed to stay in contact with the skin outside the anus. It is often used overnight so it stays in contact with both areas. Wash your hands afterward.
Rectal rockets are nonaqueous suppositories, so a USP <795> default beyond-use date of up to 180 days usually applies. Fatty bases soften in heat and should be refrigerated; polyethylene glycol bases generally do not need refrigeration. Follow the storage line on your label, keep out of reach of children, and discard after the beyond-use date.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.